Session » Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever
-
Abstract Number: 771
Von Willebrand Factor Is Localized in the Extravascular Tissue of Patients with Juvenile Scleroderma
-
Abstract Number: 772
The Study of the Novel G87V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
-
Abstract Number: 773
Chondrocytes Influence Fibroblast-like Synoviocytes from Patients with Juvenile Idiopathic Arthritis, Through the Abrogation of TGFβ Signaling, to Delay Cell Differentiation and Maturation
-
Abstract Number: 774
Identical T Cell Clones Identified over Time in the Joints of Oligoarticular Juvenile Idiopathic Arthritis Patients
-
Abstract Number: 775
Cutaneous Gene Expression Signatures in Juvenile Myositis Reveal a Prominent IFN Signature in Lesional Skin
-
Abstract Number: 776
Genetic Signatures Support Inflammation Driven Fibrosis in Localized Scleroderma
-
Abstract Number: 778
Multiple Genetic Diagnoses in a Cohort of Patients with Cryopyrin Associated Periodic Syndrome (CAPS)
-
Abstract Number: 779
The Juvenile Idiopathic Arthritis-Associated IL2RA Haplotype Contains an Intronic Enhancer Whose Function Is Diminished by JIA-Associated Genetic Variants
-
Abstract Number: 780
Changes in MiR-17-92 Cluster Expression Link Systemic Juvenile Idiopathic Arthritis, Monocyte-to-Macrophage Differentiation, and Interferon Regulation
-
Abstract Number: 781
Is down Syndrome Associated Arthritis (DA) a Distinct Disease from Juvenile Idiopathic Arthritis (JIA)?
-
Abstract Number: 782
Oligoarticular Juvenile Idiopathic Arthritis Displayed Increased Expression of Co-Inhibitory Receptors Without Signs of T-Cell Exhaustion
-
Abstract Number: 783
Differences in Chromatin Architecture in Treatment Naïve Pediatric Lupus Patients
-
Abstract Number: 784
Application of Systems Biology-Based In Silico Tools for Optimal Treatment Strategy Identification in Still’s Disease
-
Abstract Number: 785
Predictors of Response to Tumour Necrosis Factor – α Inhibitors (TNFi) in Juvenile Idiopathic Arthritis (JIA): A Single-center Experience
-
Abstract Number: 786
Distinguishing S100 Proteins and Cytokine Levels Between Active and Inactive Uveitis in Children with Juvenile Idiopathic Arthritis
-
Abstract Number: 787
Complement Protein Levels Reflect Disease Activity in Juvenile Idiopathic Arthritis
-
Abstract Number: 788
Type I Interferon Score and Interferon Induced Mediators CXCL10 and Neopterin Are Correlated with Disease Activity in Juvenile Dermatomyositis
-
Abstract Number: 789
DNASE1L3 Variant in Hypocomplementemic Urticarial Vasculitis Syndrome Identifies a Different Clinical Phenotype
-
Abstract Number: 790
Can High ANA Titre Combined with Clinical Features Predict Developing Autoimmune Conditions in Children?
-
Abstract Number: 791
Closing the Seronegative Gap in Pediatric Localized Scleroderma and Systemic Sclerosis
-
Abstract Number: 792
Speckle Tracking Echocardiography, a Sensitive Tool to Detect Early Cardiac Dysfunctions in Juvenile Systemic Sclerosis
-
Abstract Number: 793
Rituximab for Rapidly Progressive Juvenile Systemic Sclerosis: A Proof-of-concept Study in Four Patients
-
Abstract Number: 794
Mycophenolate Mofetil for the Treatment of Severe or Methotrexate-refractory Juvenile Localized Scleroderma
-
Abstract Number: 795
Is the Presentation and Severity Different of the Juvenile Diffuse and Limited Subtype Systemic Sclerosis? Results of Juvenile Scleroderma Inception Cohort
-
Abstract Number: 796
Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests: Results from the Juvenile Scleroderma Inception Cohort
-
Abstract Number: 797
Characteristics of Coexisting Localized Scleroderma and Juvenile Idiopathic Arthritis
-
Abstract Number: 799
Application of the Autoinflammatory Disease Activity Index (ADDI) to a Cohort of Patients in a Tertiary Hospital
-
Abstract Number: 800
Cryopyrin-Associated Periodic Syndrome in Korea: 19 Years of Experience